Objective-Prevalence of vitamin D (VD) deficiency and its association with the risk of cardiovascular disease prompted us to evaluate the effect of VD status on lipid metabolism and atherosclerosis in hypercholesterolemic microswine. Approach and Results-Yucatan microswine were fed with VD-deficient (0 IU/d), VD-sufficient (1000 IU/d), or VDsupplemented (3000 IU/d) high-cholesterol diet for 48 weeks. Serum lipids and 25(OH)-cholecalciferol levels were measured biweekly. Histology and biochemical parameters of liver and arteries were analyzed. Effect of 1,25(OH) 2 D 3 on cholesterol metabolism was examined in human hepatocyte carcinoma cell line (HepG2) and human monocytic cell line (THP-1) macrophage-derived foam cells. VD deficiency decreased plasma high-density lipoprotein levels, expression of liver X receptors, ATP-binding membrane cassette transporter A1, and ATP-binding membrane cassette transporter G1 and promoted cholesterol accumulation and atherosclerosis in hypercholesterolemic microswine. VD promoted nascent highdensity lipoprotein formation in HepG2 cells via ATP-binding membrane cassette transporter A1-mediated cholesterol efflux. Cytochrome P450 (CYP)27B1 and VD receptor were predominantly present in the CD206 + M2 macrophage foam cell-accumulated cores in coronary artery plaques. 1,25(OH) 2 D 3 increased the expression of liver X receptors, ATPbinding membrane cassette transporter A1, and ATP-binding membrane cassette transporter G1 and promoted cholesterol efflux in THP-1 macrophage-derived foam cells. 1,25(OH) 2 D 3 decreased intracellular free cholesterol and polarized macrophages to M2 phenotype with decreased expression of tumor necrosis factor-α, interleukin-1β, interleukin-6 under lipopolysaccharide stimulation. 1,25(OH) 2 D 3 markedly induced CYP27A1 expression via a VD receptor-dependent c-Jun N-terminal kinase (JNK) 1/2 signaling pathway and increased 27-hydroxycholesterol levels, which induced liver X receptors, ATP-binding membrane cassette transporter A1, and ATP-binding membrane cassette transporter G1 expression and stimulated cholesterol efflux that was inhibited by VD receptor antagonist and JNK1/2 signaling inhibitor in THP-1 macrophage-derived foam cell. Conclusions-VD protects against atherosclerosis in hypercholesterolemic swine via controlling cholesterol efflux and macrophage polarization via increased CYP27A1 activation. The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
A therosclerosis is a chronic inflammatory disease characterized by accumulation of macrophages in the arterial intima, which along with an associated inflammatory response in blood vessel walls initiates the formation and progress of atherosclerotic lesions. 1 In atherosclerotic plaques, macrophage-derived foam cell formation is a hallmark of the progression of atherosclerosis that incites inflammatory rupture of plaques and leads to life threatening cardiovascular complications. 2 It is well established that an atherogenic lipid profile, including increased serum low-density lipoprotein (LDL), promotes the massive accumulation of cholesterol in macrophages, whereas high-density lipoprotein (HDL) inhibits macrophages-derived foam cell formation via promoting cholesterol efflux and transporting it to the liver for excretion, a process termed reverse cholesterol transport. 3 In atherosclerotic lesions, macrophages are submitted to microenvironmental factors, including cytokines and lipid signals, which might differentiate these cells into morphologically and functionally distinct phenotypes that are usually characterized by the classical proinflammatory M1 macrophages and alternatively activated anti-inflammatory M2 macrophages. 4 Several ligand-activated nuclear hormone receptors, such as liver X receptor-α (LXR-α) and peroxisome proliferatoractivated receptor-γ, are important lipid sensors that not only regulate expression of genes involved in lipid metabolism but also regulate macrophage polarization. 5 Vitamin D (VD) deficiency has been rising in the general population. Approximately 50% of the population worldwide has low levels of plasma 25-hydroxyvitamin D (25(OH)D 3 <20 ng/mL), a stable marker of VD status. 6 Beyond its well-defined role in calcium homeostasis, VD has recently been identified as an important factor in cardiovascular health. 7, 8 Clinical studies have indicated that plasma 25(OH)D 3 level below 20 ng/mL is associated with increased risk for coronary heart disease. 9 Several mechanisms, including protection of endothelial function, modulation of immune response, inhibition of vascular smooth muscle cell growth, have been proposed to account for the antiatherosclerotic effect of VD. 7 Recently, several large retrospective studies demonstrated that VD deficiency is associated with atherogenic lipid profile, including increased serum LDL and decreased HDL levels. 10, 11 High 25(OH)D 3 concentrations in the elderly are associated with low prevalence of metabolic syndrome with more beneficial HDL cholesterol (HDL-C) levels. 12 1,25(OH) 2 D 3 , the biologically active form of VD, suppresses foam cell formation by reducing oxidized LDL uptake in diabetic subjects. 13 However, repletion of 25-hydroxyvitamin D levels in the short term has been reported not to improve the lipid profile in human. 14 Thus, further studies are warranted to define the exact role of VD on the lipid metabolism and atherosclerosis.
In the present study, we found that VD deficiency decreased plasma HDL levels and promoted the progression of atherosclerosis in hypercholesterolemic swine via impaired LXRs/ ATP-binding membrane cassette transporter A1 (ABCA1) pathway, a crucial regulator in the formation and function of HDL. Our experiments revealed that 1,25(OH) 2 D 3 promotes nascent HDL formation in human hepatocyte carcinoma cell line (HepG2) cells via ABCA1-mediated cholesterol efflux. In human monocytic cell line (THP-1) macrophages-derived foam cell, 1,25(OH) 2 D 3 increased the expression of LXRs, ABCA1, and ATP-binding membrane cassette transporter G1 (ABCG1) and promoted cholesterol efflux and polarized macrophages to an M2 phenotype with decreased expression of inflammatory cytokines under lipopolysaccharide stimulation. 1,25(OH) 2 D 3 causes upregulation of cytochromes P450 (CYP)27A1 via a VD receptor (VDR)-dependent c-Jun N-terminal kinase (JNK) 1/2 signaling, which plays a crucial role in the activation of LXRs/ABCA1/ABCG1 pathway.
Materials and Methods
Materials and methods are available in the online-only Data Supplement.
Results

VD Deficiency Decreases Plasma HDL Level and Promotes Atherosclerosis in Hypercholesterolemic Swine
To investigate the effect of VD on the lipid metabolism and the progression of atherosclerosis, microswine were fed on VD-deficient (VD Def), VD-sufficient (VD Suf), and VD-supplemented (VD Sup) high-cholesterol diets. As shown in Figure 1A , VD Def diet produced significant VD deficiency, whereas VD Sup diet increased the serum level of 25(OH)D 3 , a stable marker of VD status. Lipid levels of animals fed with high-cholesterol diets were increased with time. Compared with VD Suf group, a significant decrease in HDL-C was observed as early as the end of the third month in VD Def group (VD Def group, 68.4±7.9 mg/dL; VD Suf group, 87.8±6.2 mg/dL; VD Sup group, 98.5±10.3 mg/dL; P<0.01). Furthermore, the VD Sup group had significantly higher level of HDL-C at month 12 compared with the VD Suf group (VD Sup group, 117.3±12.8 mg/dL; VD Suf group, 98.3±9.6 mg/ dL; P<0.05; Figure 1B ). Compared with VD Suf group, VD deficiency increased while VD supplementation decreased the levels of LDL cholesterol. Nevertheless, there was no statistically significant difference among these groups ( Figure 1B) .
To investigate the effect of VD status on the atheroma progression in hypercholesterolemic swine, the histological analyses of fatty streak in thoracic aorta from different treatment groups were compared. As shown in Figure 1C , relative aortic fatty streak lesion area was 49.35±6.17% for the VD Def group, 34.11±2.56% for the VD Suf group, and 24.28±3.05% for the VD Sup group (P<0.01, VD Def compared with VD Suf or VD Sup; P<0.05, VD Sup compared with VD Suf), suggesting that VD deficiency resulted in a more remarkable progress in aortic fatty streak lesions formation under highcholesterol diet. To further evaluate the extent of atherosclerosis, common carotid arteries from 3 dietary groups were analyzed for total cholesterol and cholesteryl ester deposition ( Figure 1D ). Total cholesterol contents of the arteries were significantly higher in the swine from VD Def group than in swine from the VD Suf or VD Sup group (P<0.01, 58.9±9.81 versus 36.8±5.28 μmol/g artery or 58.9±9.81 versus 35.5±4.44 μmol/g artery). Free cholesterol content in the common carotid artery was significantly increased by 73.2% or 93.2% in the VD Def group compared with VD Suf or VD Sup groups, respectively, further suggesting that VD deficiency exacerbates the lipid accumulation and atherosclerosis in hypercholesterolemic microswine.
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VD Deficiency Decreases 27-Hydroxycholesterol Level in Liver of Hypercholesterolemic Swine
To examine the molecular signaling targets that could explain the difference in HDL levels response to VD status, we first performed microarray analysis to examine differentially expressed genes in liver, which is the major organ for the synthesis of HDL. A total of 24 124 genes were examined using the porcine GeneChip for liver of pigs (n=4 for each treatment groups). A total of 342 mRNAs were identified as being up-or downregulated >2-fold in the VD Def group compared with VD Suf and VD Sup groups. Of these genes, 38 genes were regulated in a VD dose-dependent manner. Analysis of these genes using Gene Ontology Biological Process revealed that differential expression of genes primarily regulates the following biological functions: oxidative stress, lipid metabolism and inflammatory response, and cell signaling and interactions ( Table I in the online-only Data Supplement). These results support the concept that in addition to its established role in regulating calcium homeostasis, VD seems to play an important role in the modulation of metabolic inflammatory diseases, including atherosclerosis. Prominent effects of VD on the genes in the lipid metabolism were noted. Interestingly, the transcription of genes encoding oxysterol receptor LXR pathway, ligand-activated transcription factors that raise HDL-C levels, was significantly decreased in the VD Def group ( Table I in the online-only Data Supplement and Figure 2A ). After further validation by Western blot, the key proteins in the LXR pathway, including LXR-α and LXR-β, its target gene ABCA1, and steroid catabolic gene CYP27A1 were decreased in VD Def group compared with VD Suf and VD Sup groups ( Figure 2B ). CYP27A1 plays a crucial role in the biogenesis of oxysterols, crucial ligands for the activation of LXRs. To clarify whether the regulated effect of VD on the HDL metabolism is related to the oxysterol metabolism, the levels of steroid catabolic intermediates, including 27-hydroxycholesterol (HOC), desmosterol, and 24,25-epoxycholesterol, in the liver were measured in the 3 groups. Compared with VD Suf and VD Sup groups, VD deficiency decreased the levels of 27-HOC. However, there was no significant difference in the levels of desmosterol and 24,25-epoxycholesterol in the 3 groups ( Figure 2C ). In the cultured HepG2 cell, 1,25(OH) 2 D 3 (10 nM) treatment substantially upregulated the expression of CYP27A1 in a time-dependent manner ( Figure 2D ) and increased 27-HOC concentrations in oxidized LDL-loaded HepG2 cells ( Figure 2E ). The activation of LXRs by oxysterol ligands induces the expression of ABCA1, which interacts with apolipoprotein A-I (apoA-I) and promotes the cholesterol efflux that plays a crucial role in the biogenesis of nascent HDL. 15, 16 Because 1,25(OH) 2 D 3 increases 27-HOC production in HepG2 cells, we investigated whether 1,25(OH) 2 27-HOC (1 μM), and 1,25(OH) 2 D 3 (10 nM), respectively, for 18 h and then incubated with lipid-free apoA-I (25 μg/mL) for 12 h. The medium was collected and filtered through a 0.45 μm polyvinylidene fluoride membrane to separate non-HDL and HDL. The radioactivity in [ 3 H]-HDL fraction was determined by liquid scintillation counter. We found that the 1,25(OH) 2 D 3 and the LXR agonist T0901317 and 27-HOC significantly increased cholesterol efflux to apoA-I ( Figure 2F ). After the incubation, ABCA1 protein expression in HepG2 cells was markedly increased by T0901317, 27-HOC, and 1,25(OH) 2 D 3 ( Figure 2G ). Overall, these data suggest that 1,25(OH) 2 D 3 promotes the nascent HDL formation in HepG2 cells by upregulating CYP27A1 activity and ABCA1 expression.
VD Increases Cholesterol Efflux and M2 Polarization in Coronary Artery of Hypercholesterolemic Swine
To determine the exact mechanism of VD on the inhibition of atherosclerotic progress, we stained coronary plaques from hypercholesterolemic swine. As shown in Figure 3A , VD metabolism, signal-related proteins, including CYP27B1, and VDR were predominantly present in the macrophage foam cell-accumulated cores of plaques in coronary artery. Vitamin D3 and its biologically active form, 1,25(OH) 2 D 3 , have been confirmed to have crucial effects on macrophage function via binding to its receptor VDR. 7 Therefore, this data suggest that VD-mediated inhibition of atherosclerosis may be the result from the direct effect of VD on arterial wall, besides its effect on HDL levels. Macrophages, with extreme polarization phenotypes M1 and M2 macrophages, are the major cell components in atherosclerotic lesion that contribute to the foam cell formation and secretion of inflammatory factors. To clarify the exact role of VD in macrophage function, we compared the staining intensity between M1 marker CCR7 and M2 marker mannose receptor (CD206) in the regions of CYP27B1-positive and VDR-positive cores in plaques. We found significantly greater staining of M2 macrophage marker, CD206, in VDR-positive area, whereas proinflammatory M1 macrophage marker CCR7 showed minimal immunoreactivity in this area ( Figure 3A ), suggesting that VD may play a role in the regulation of macrophage differentiation and inflammatory response in atherosclerotic lesion. To verify this hypothesis, we examined the expression of proinflammatory cytokines (tumor necrosis factor-α and interleukin (IL)-1β) in the left common carotid arteries. As shown in Figure 3B , there was significantly increased level of proinflammatory cytokines in the VD Def group compared with the VD Suf or VD Sup groups (P<0.05, VD Def versus VD Suf or VD Sup). As shown in Figure 3C , ABCA1 and ABCG1, another LXR-α target genes primarily expressed in macrophages, are mainly coexpressed with VDR at the sites of M2 macrophage foam cells in coronary atherosclerotic lesions of hypercholesterolemic swine, suggesting that the ABCA1/ABCG1 in macrophage might be regulated targets for the VD treatment. Therefore, we next examined the effect of VD on the expression of LXR-α/β, ABCA1, and ABCG1 in macrophages. Western blot results in Figure 3D showed that the VD level positively correlated to the expression of ABCA1, ABCG1, and LXRα/β in artery of hypercholesterolemic swine, suggesting that the enhanced effect of VD deficiency on atherosclerosis might be related to the impaired cholesterol efflux in the arterial wall.
1,25(OH) 2 D 3 Promotes Cholesterol Efflux and M2 Polarization in Macrophage-Derived Foam Cells via Upregulating 27-HOC
To further determine whether 1,25(OH) 2 D 3 altered cholesterol efflux in macrophages, we analyzed the effect of 1,25(OH) 2 D 3 on ABCA1-mediated cholesterol efflux in THP-1 macrophage-derived foam cells. As shown in Figure 4A , oxidized LDL-induced macrophage-derived foam cells cultured in 1,25(OH) 2 D 3 -deficient media exhibited a significantly greater staining in oil red after treatment with apoA-I compared with macrophage-derived foam cells cultured in 1,25(OH) 2 D 3 -supplemented media. Next, we examined the effect of 1,25(OH) 2 D 3 on cholesterol content and cholesterol efflux in THP-1 macrophage-derived foam cells. As shown in Figure 4B and 4C, the ability of apoA-I to decrease cholesterol content and to promote cholesterol efflux in THP-1 macrophage-derived foam cell was significantly increased in 1,25(OH) 2 D 3 -supplemented media compared with 1,25(OH) 2 D 3 -deficient media. To determine whether the increased ability of apoA-I to promote cholesterol efflux in 1,25(OH) 2 D 3 -supplemented media is related to cholesterol transporters, we analyzed the expression of ABCA1 and ABCG1 in these cells. Analysis of protein levels by Western blotting demonstrated a 1,25(OH) 2 D 3 -induced upregulation in the levels of ABCA1 and ABCG1 expression in THP-1 macrophage-derived foam cells ( Figure 4D ).
Macrophages-derived foam cells from atherosclerotic subjects have been shown to exhibit classic (M1) proinflammatory phenotype. 5, 17 LXR-α activation and increasing ABCA1 levels have been found to inhibit inflammation and induce expression of IL-10, a marker of the M2 macrophage phenotype. 18, 19 To investigate whether the increased activation of LXR-α induced by 1,25(OH) 2 D 3 results in the macrophage phenotypic polarization, we compared the expression of M1 or M2 marker in basal, IL-4, or lipopolysaccharide condition. Compared with 1,25(OH) 2 D 3 -deficient media, the macrophages from 1,25(OH) 2 D 3 -supplemented media have a significant increase in IL-4-stimulated mRNA expression of CD206 and MGL-1 ( Figure 4E ). Cells were analyzed by fluorescenceactivated cell sorter using anti-mannose receptor CD206 antibody. As shown in Figure 4F promotes the M2 polarization of macrophage-derived foam cells. In vitro stimulation with lipopolysaccharide demonstrated that macrophages from 1,25(OH) 2 D 3 -supplemented media produced significantly less proinflammatory cytokine, tumor necrosis factor-α, compared with macrophages from 1,25(OH) 2 D 3 -deficient media ( Figure 4G) . These results support the concept that 1,25(OH) 2 D 3 in macrophage is antiatherogenic via promotion of cholesterol efflux and antiinflammatory macrophage polarization by upregulating LXRα pathway.
To clarify whether the regulated effect of 1,25(OH) 2 D 3 on macrophage is dependent on 27-HOC, we investigated the effect of 1,25(OH) 2 D 3 on macrophage CYP27A1 expression. 1,25(OH) 2 D 3 treatment substantially increased the expression of CYP27A1 in THP-1 macrophage-derived foam cells ( Figure 4H ). We also examined the effect of 27-HOC on the expression of ABCA1 and ABCG1 and found that 27-HOC induced ABCA1 and ABCG1 expression in a dose-dependent manner in THP-1 macrophage-derived foam cells ( Figure I in the online-only Data Supplement). These results suggest that the 27-HOC/LXR-α pathway plays a crucial role in the regulation of macrophage cholesterol efflux and anti-inflammatory effect of 1,25(OH) 2 D 3.
1,25(OH) 2 D 3 Induces 27-Hydroxycholesterol in a VDR-Dependent JNK Signal Manner
CYP27A1 expression is controlled by activated JNK signal. 20, 21 In multiple cell types, the JNK pathway has been demonstrated to be activated by 1,25(OH) 2 D 3 . [20] [21] [22] After treatment with 1,25(OH) 2 D 3 for 30 minutes, the phosphorylation of JNK1/2 in THP-1 macrophage-derived foam cells was detected, and it was further enhanced ≤3 h ( Figure 5A ). We further used JNK signal inhibitor SP600125 to determine whether 1,25(OH) 2 D 3 is exerting its CYP27A1 induction effects through activated JNK signal. THP-1 macrophage-derived foam cells were exposed to SP600125 or 1,25(OH) 2 D 3 . SP600125 almost completely blocked 1,25(OH) 2 D 3 -induced expression of phosphorylation of JNK1/2 in THP-1 macrophages ( Figure 5B ). The ability of 1,25(OH) 2 D 3 to induce CYP27A1, ABCA1, and ABCG1 mRNA expression in THP-1 macrophagederived foam cells was significantly impaired by SP600125 ( Figure 5C ), suggesting that 1,25(OH) 2 D 3 -induced CYP27A1 expression is mediated by the JNK signaling pathway.
To test the role of VDR on the effect of 1,25(OH) 2 D 3 on CYP27A1 in THP-1 macrophage-derived foam cells, we first incubated cells with 100 nmol/L VDR siRNA, and the expression of VDR was almost completely inhibited by siRNA ( Figure 5D ). The ability of 1,25(OH) 2 D 3 to induce expression of CYP27A1 in THP-1 macrophage-derived foam cells was also significantly inhibited in VDR siRNA-treated cells ( Figure 5E ). We then confirmed a role of VDR in the 1,25(OH) 2 D 3 -mediated increase of cholesterol efflux in VDR knockdown cells. The effect of 1,25(OH) 2 D 3 on ABCA1, ABCG1, and LXR-α expression in VDR siRNA cells was significantly abolished compared with control siRNA-untreated cells ( Figure 5F) , indicating a VDR-dependent effects of 1,25(OH) 2 D 3 on LXR-α and its target genes. We further examined the role of VDR in the 1,25(OH) 2 D 3 -induced cholesterol efflux using liquid scintillation counter. The ability of 1,25(OH) 2 D 3 -induced cholesterol efflux in VDR siRNA cells was markedly decreased compared with that in control siRNA-treated cells ( Figure 5G ).
Discussion
Although clinical studies suggest that VD deficiency is related to a higher risk for cardiovascular disease, the exact role of VD in the progression of cardiovascular diseases has not been well defined. 23 Because a higher plasma VD concentration is usually associated with a healthier lifestyle, it is unclear whether VD status is causally related to disease or is merely a marker of health. 8, 10 In this study, we fed hypercholesterolemic swine with different VD diet, resulting in different plasma 25(OH) D levels that provide the direct evidence for the effect of VD status on the progress of the disease. We found that VD deficiency promoted the progress of atherosclerosis and decreased plasma HDL-C level, a crucial cardiovascular protective factor, under hypercholesterolemic condition. Supplementation of vitamin D 3 in the diet (3000 IU per day×24 weeks) significantly prevented the development of atherosclerosis and increased the level of HDL-C, suggesting the beneficial effect of vitamin D 3 supplementation in modifying lipid profile and decreasing cardiovascular disease. In a randomized clinical study, including 57 postmenopausal VD Def women, Catalano et al found that the supplementation with 25(OH)D 3 (calcifediol) for 24 weeks significantly increased HDL-C level even after adjustment for age, baseline body mass index, 25(OH) D 3 , and lipid levels. 24 In another randomized double-blind placebo-controlled clinical trial, including 70 participants with type 2 diabetes mellitus, it was found that the supplementation of calcitriol (1,25(OH) 2 D 3 , 0.5 μg per day) for 12 weeks increased the HDL-C level compared with the placebo group. 25 However, Ponda et al have reported no improvement in the lipid profile after short-term supplementation of vitamin D 3 (50 000 IU of vitamin D3 weekly for 8 Weeks) in VD Def adults with elevated risk for cardiovascular disease, suggesting that the dose and duration of treatment determine the outcomes, and this remains to be elucidated.
Oxysterols are the endogenous ligands for the LXRs, ligand-activated transcription factors that can regulate a crucial checkpoint in cholesterol homeostasis. 26 The sterol 27-hydroxylase (CYP27A1) is a mitochondrial cytochrome P450 and is involved in the synthesis of oxysterols, HOC, 3β-hydoxy-5-cholestenoic acid, and 25(OH)D 3 , which play a crucial role in cholesterol, bile acids, and VD metabolism. 27 It was reported previously that vitamin D 3 and its biologically active form, 1,25(OH) 2 D 3, can regulate expression of various CYP. [28] [29] [30] Using a microarray method, we found that VD deficiency induces a response for the expression of the mRNA of genes associated with oxidative stress, lipid metabolism, and inflammation pathways in the liver. VD supplementation increased liver mRNA levels of oxidation-reduction and oxysterol-related CYP genes, including CYP1A1, CYP1A2, CYP2J34, and CYP27A1. In addition, we found that VD upregulates the expression of LXRs and ABCA1 in liver in a dose-dependent manner.
ABCA1 is a lipid transport protein transcriptionally regulated by nuclear receptors LXR-α, which facilitates cellular cholesterol efflux to lipid-poor apoA-I and plays a key role in the formation and function of HDL. 31 In mice, specific lack of ABCA1 in hepatocytes almost totally reduces the circulating HDL-C level. 32 Mutations of ABCA1 in human underlie the HDL deficiency syndrome, Tangier disease, suggesting that primarily hepatic ABCA1 determines the generation of nascent HDL particles. 31, 32 To clarify whether the regulated effect of VD on the HDL metabolism is related to the ABCA1 expression, we investigated the effect of 1,25(OH) 2 D 3 on the expression of ABCA1 and nascent HDL formation in hepatocytes and found that 1,25(OH) 2 D 3 promoted cellular cholesterol efflux to lipid-poor apoA-I, a major component of nascent HDL via upregulating ABCA1 expression. In several cholesterolloaded cells, including hepatocytes and macrophages, LXR-α/ ABCA1 pathway has been found to be upregulated to promote the cholesterol efflux via a 27-HOC-dependent manner. 33, 34 In this study, we have shown for the first time that 1,25(OH) 2 D 3 facilitates the upregulation of LXR-α/ABCA1 in cholesterolloaded hepatocytes and macrophages via promoting the expression of CYP27A1. This effect could be supported by a recent clinical data, showing a significant positive correlation between the levels of 27-OHC and 25(OH)D 3 under hypercholesterolemic condition. 35 Interestingly, the LXR target genes, such as ABCG5/8, SREBP-1c, and SR-B1, were not found to be regulated by 1,25(OH) 2 D 3 in hepG2 cells ( Figure II in the online-only Data Supplement). The conserved consensus cis-acting element DR4-dependent transcription is necessary for LXR-α-induced ABCA1 expression in HepG2 cells. 36 The activation of VDR by 1,25(OH) 2 D 3 has been found to recruit coactivators at DR4-type response element that leads to the expression of target genes. 37, 38 These results suggest that the recruitment of coactivators at the response element induced by 1,25(OH) 2 D 3 may be playing a critical role in supporting the transactivation of LXR-α/ABCA1 pathway, though the exact mechanisms remain to be further examined.
Several studies have shown that 1,25(OH) 2 D 3 can regulate the differentiation, maturation, and function of macrophages, 7, 39, 40 which prompted us to investigate whether the antiatherogenic effects of VD results from the direct effect of VD on the arterial wall. In this study, we found that VDR and CYP27B1, a key enzyme to control the synthesis of 1,25(OH) 2 D 3 , are mainly expressed at the M2 macrophage foam cell-accumulated cores of plaques in the coronary artery. VD regulates the macrophage M1/M2 phenotype in diabetic nephropathy rats. 36 In vitro, 1,25(OH) 2 D 3 has also been found to switch high glucose-induced M1/M2 polarization to suppress cholesteryl ester formation and to enhance cholesterol efflux in M2 macrophages. 41, 42 In atherosclerotic lesion, we found that VDR is primarily coexpressed with ABCA1/ABCG1 at M2 macrophage-derived foam cell. In vitro, 1,25(OH) 2 D 3 has been found to promote the cholesterol efflux and polarize macrophages to proinflammatory M2 phenotype. In macrophages, ABCA1 and ABCG1, another ABC family of transporter, play critical role in mobilizing cholesterol out of macrophages and onto extracellular HDL. 43 In addition to its lipid transport function, ABCA1 and ABCG1 have been found to play a crucial role in the regulation of cytokine-triggered macrophage polarization programs and inflammatory response. 44, 45 Several studies have shown that the cholesterol export activity of ABCA1/ ABCG1 could account for its potent anti-inflammatory properties. 46, 47 Knockdown of ABCA1 in macrophage results in an increase of cell membrane cholesterol and lipid raft content, which facilitate toll-like receptor 4-MyD88-mediated proinflammatory response. 48 In this study, we found that 1,25(OH) 2 D 3 markedly induced the expression of ABCA1 and ABCG1 in macrophages, suggesting that enhanced cholesterol efflux may play a crucial role in anti-inflammatory effect of VD.
Previously, JNK/c-jun pathway has been reported to upregulate the expression of CYP27A1 in hepatocytes. 20 1,25(OH) 2 D 3 activates the JNK/c-jun pathway in various cell lines. 21, 22, 49 Consistently, our study demonstrated that 1,25(OH) 2 D 3 upregulates the phosphorylation of JNK in macrophages. Furthermore, inhibitor of JNK activation blocks 1,25(OH) 2 D 3 -induced upregulation of CYP27A1 and 27-HOC content, suggesting that JNK/c-Jun activation plays an important role in antiatherogenic activity of VD. Both VDR and LXR-α are crucial lipid-activated nuclear receptors that shape macrophage function. 50 Earlier studies have shown that VDR is regulated by LXR-α through its ability to modulate sterol regulatory element-binding protein present in the promoter region of VDR gene. 51 In our study, we found that LXR-α pathway is also regulated by VDR through its ability to modulate CYP27A1 and 27-HOC ( Figure 6 ), suggesting the existence of crosstalk between LXR and VDR that stimulates the intracellular pathway to exert the antiatherogenic effect.
In conclusion, the findings in this study revealed a novel mechanistic link between VD deficiency and cardiovascular risk. VD supplementation significantly increased the levels of plasma HDL and the expression of 27-HOC/LXR-α pathway, which contributes to alleviate cholesterol toxicity and macrophage proinflammatory polarization, resulting in protection against the development of atherosclerosis.
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